Clinical Trials Browser

OTHER × tepotinib × Gastrointestinal × Clear all

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT05439993 2022-07-05

Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms